649
Participants
Start Date
June 16, 2020
Primary Completion Date
February 1, 2021
Study Completion Date
March 8, 2021
Remdesivir
Participants will receive intravenous (IV) RDV
Tocilizumab
Participants will receive IV TCZ
Placebo
Participants will receive IV placebo matched to TCZ
Wyckoff Heights Medical Center, Staten Island
Lehigh Valley Hospital, Allentown
Hospital General Universitario de Guadalajara, Guadalajara
Thomas Jefferson University, Philadelphia
Medstar Georgetown University Hospital, Washington D.C.
University of Maryland, Baltimore
West Virginia University Hospital, Morgantown
Hospital Universitario Principe de Asturias; Medicina Interna - Servicio de Enfermedades Infecciosas, Alcalá de Henares
Hospital Universitario Fundacion Jimenez Diaz., Madrid
Novant Health Clinical Research, Charlotte
Hospital Universitario HM Torrelodones, Torrelodones
Medical University of South Carolina, Charleston
Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah
University of Miami Miller School of Medicine; Clinical Reseach Building, Miami
Larkin Community Hospital, South Miami
Holy Cross Hospital Inc, Fort Lauderdale
OhioHealth Research Institute, Columbus
Henry Ford Medical Center, Novi
Advocate Christ Medical Center, Oak Lawn
Ochsner Clinic Foundation, New Orleans
Baylor Scott & White Medical Center - Irving, Irving
Baylor Scott & White Hospital - Plano, Plano
Baylor University Medical Center, Dallas
The Liver Institute at Methodist Dallas, Arlington
Baylor Scott & White Health, Temple
Baylor St. Luke's Medical Center, Houston
Ben Taub General Hospital - HCHD, Houston
Houston Methodist Hospital, Houston
Baylor Scott and White Medical Center - College Station, College Station
St Luke's Health System; Rheumatology Research, Boise
Intermountain LDS Hospital, Salt Lake City
Valleywise Health Medical Center, Phoenix
San Juan Oncology Associates, Farmington
Providence St Johns Health Center, Santa Monica
eStudySite - Chula Vista - PPDS, Chula Vista
Hoag Hospital Irvine, Irvine
Providence Saint Vincent's Medical Center, Portland
The Providence Regional Medical Center Everett, Everett
O.M. Filatov City Clinical Hospital #15; Department of Surgery, Moskva
City Clinical Hospital # 52, Moscow
Medsi Clinic, Moscow
City Pokrovskaya Hospital, Saint Petersburg
Yale University School of Medicine; HIV Clinical Trials Program, New Haven
Boston Medical Center, Boston
Baystate Medical Center, Springfield
St. Michael'S Medical Center, Newark
Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte
Hospital Nossa Senhora das Graças; Setor de Pesquisa em Neurologia, Curitiba
Instituto de Pesquisa Clinica Evandro Chagas - IPEC FIOCRUZ, Rio de Janeiro
CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo do Campo
Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto
Instituto de Infectologia Emilio Ribas, São Paulo
Instituto do Coração - HCFMUSP, São Paulo
Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat
Collaborators (1)
Gilead Sciences
INDUSTRY
Hoffmann-La Roche
INDUSTRY